問卷

TPIDB > Search Result > Clinical Trials List

Clinical Trials List

Protocol NumberR3918-PNH-2050
Active

2023-03-01 - 2028-10-16

Phase III

Not yet recruiting7

Recruiting1

ICD-10D59.5

Paroxysmal nocturnal hemoglobinuria [Marchiafava-Micheli]

ICD-10D59.6

Hemoglobinuria due to hemolysis from other external causes

ICD-10D59.8

Other acquired hemolytic anemias

ICD-9283.2

Hemoglobinuria due to hemolysis from external causes

  • Sponsor

  • Trial scale

    Multi-Regional Multi-Center

  • Update

    2026/04/01

Investigators and Locations

Principal Investigator 陳宇欽 Division of Hematology & Oncology

Co-Principal Investigator

The Actual Total Number of Participants Enrolled

0 Not yet recruiting

Principal Investigator Su-Peng Yeh Division of Hematology & Oncology

Co-Principal Investigator

The Actual Total Number of Participants Enrolled

0 Not yet recruiting

Principal Investigator 黃威翰 Division of Hematology & Oncology

Co-Principal Investigator

  • 黃聖娟 Division of Hematology & Oncology

The Actual Total Number of Participants Enrolled

0 Not yet recruiting

Principal Investigator Hui-Hua Hsiao 未分科

Co-Principal Investigator

The Actual Total Number of Participants Enrolled

0 Not yet recruiting

Principal Investigator 林炫聿 Division of Hematology & Oncology

Co-Principal Investigator

The Actual Total Number of Participants Enrolled

0 Not yet recruiting

Principal Investigator Tsai-Yun Chen 未分科

Co-Principal Investigator

The Actual Total Number of Participants Enrolled

0 Not yet recruiting

Principal Investigator HSIN-AN HOU 未分科

Co-Principal Investigator

The Actual Total Number of Participants Enrolled

0 Not yet recruiting

Principal Investigator

Co-Principal Investigator

The Actual Total Number of Participants Enrolled

0 Recruiting

Principal Investigator

Co-Principal Investigator

  • 高小雯 Division of Hematology & Oncology

Condition/Disease

Objectives

Test Drug

Active Ingredient

Dosage Form

Dosage

Endpoints

Inclution Criteria

The Estimated Number of Participants

  • Taiwan

    26 participants

  • Global

    202 participants